T cells as the hoped-for savior for SARS-CoV-2 vaccination during CD20-depleting antibody therapy?

by Gabriel Bsteh, Johann Sellner
Published 2021-12-01

Measuring Treatment Response in Progressive Multiple Sclerosis—Considerations for Adapting to an Era of Multiple Treatment Options

by Nik Krajnc, Thomas Berger, Gabriel Bsteh
Published 2021-09-01

Expansion of Neutrophils and Classical and Nonclassical Monocytes as a Hallmark in Relapsing-Remitting Multiple Sclerosis

by David Haschka, Piotr Tymoszuk, Gabriel Bsteh, Gabriel Bsteh, Verena Petzer, Klaus Berek, Igor Theurl, Thomas Berger, Günter Weiss
Published 2020-04-01

Clinical and Paraclinical Biomarkers and the Hitches to Assess Conversion to Secondary Progressive Multiple Sclerosis: A Systematic Review

by Nik Krajnc, Nik Krajnc, Gabriel Bsteh, Thomas Berger
Published 2021-08-01

Ecological validity of walking capacity tests following rehabilitation in people with multiple sclerosis.

by Rainer Ehling, Gabriel Bsteh, Andreas Muehlbacher, Kay Hermann, Christian Brenneis
Published 2019-01-01

Immunosenescence in Neurological Diseases—Is There Enough Evidence?

by Paulus S Rommer, Gabriel Bsteh, Tobias Zrzavy, Romana Hoeftberger, Thomas Berger
Published 2022-11-01

Clinical scales in autoimmune encephalitis—A retrospective monocentric cohort study

by Stefan Macher, Gabriel Bsteh, Romana Höftberger, Thomas Berger, Paulus Rommer, Tobias Zrzavy
Published 2023-10-01

Remote visits for people with multiple sclerosis during the COVID-19 pandemic in Austria: The TELE MS randomized controlled trial

by Patrick Altmann, Fritz Leutmezer, Markus Ponleitner, Dominik Ivkic, Nik Krajnc, Paulus Stefan Rommer, Thomas Berger, Gabriel Bsteh
Published 2022-07-01

Longitudinal ventricular cerebrospinal fluid profile in patients with spontaneous subarachnoid hemorrhage

by Anne Zinganell, Gabriel Bsteh, Franziska Di Pauli, Verena Rass, Raimund Helbok, Janette Walde, Florian Deisenhammer, Harald Hegen
Published 2022-07-01

Cerebrospinal Fluid Findings in 541 Patients With Clinically Isolated Syndrome and Multiple Sclerosis: A Monocentric Study

by Klaus Berek, Gabriel Bsteh, Michael Auer, Franziska Di Pauli, Anne Zinganell, Thomas Berger, Florian Deisenhammer, Harald Hegen
Published 2021-06-01

Stability and predictive value of anti-JCV antibody index in multiple sclerosis: A 6-year longitudinal study.

by Harald Hegen, Michael Auer, Gabriel Bsteh, Franziska Di Pauli, Tatiana Plavina, Janette Walde, Florian Deisenhammer, Thomas Berger
Published 2017-01-01

Conversion and reversion of anti‐John Cunningham virus antibody serostatus: A prospective study

by Michael Auer, Harald Hegen, Johann Sellner, Katrin Oppermann, Gabriel Bsteh, Franziska Di Pauli, Thomas Berger, Florian Deisenhammer
Published 2019-07-01

Association of Cerebrospinal Fluid Parameters and Neurofilament Light Chain With Retinal Nerve Fiber Layer Thickness in Multiple Sclerosis

by Nik Krajnc, Patrick Altmann, Katharina Riedl, Christoph Mitsch, Thomas Berger, Fritz Leutmezer, Paulus Rommer, Berthold Pemp, Gabriel Bsteh
Published 2022-03-01

MRI features of idiopathic intracranial hypertension are not prognostic of visual and headache outcome

by Gabriel Bsteh, Wolfgang Marik, Nik Krajnc, Stefan Macher, Christoph Mitsch, Philip Pruckner, Klaus Novak, Christian Wöber, Berthold Pemp
Published 2023-07-01

Impact of Disease-Modifying Treatments on the Longitudinal Evolution of Anti-JCV Antibody Index in Multiple Sclerosis

by Harald Hegen, Janette Walde, Gabriel Bsteh, Michael Auer, Sebastian Wurth, Anne Zinganell, Franziska Di Pauli, Florian Deisenhammer, Thomas Berger
Published 2018-10-01

Long Term Clinical Prognostic Factors in Relapsing-Remitting Multiple Sclerosis: Insights from a 10-Year Observational Study.

by Gabriel Bsteh, Rainer Ehling, Andreas Lutterotti, Harald Hegen, Franziska Di Pauli, Michael Auer, Florian Deisenhammer, Markus Reindl, Thomas Berger
Published 2016-01-01

Subarachnoid haemorrhage or traumatic lumbar puncture. Differentiation by cerebrospinal fluid parameters in a multivariable approach

by Anne Zinganell, Klaus Berek, Gabriel Bsteh, Franziska Di Pauli, Verena Rass, Raimund Helbok, Janette Walde, Florian Deisenhammer, Harald Hegen
Published 2023-12-01

Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension

by Nik Krajnc, Bianca Itariu, Stefan Macher, Wolfgang Marik, Jürgen Harreiter, Martin Michl, Klaus Novak, Christian Wöber, Berthold Pemp, Gabriel Bsteh
Published 2023-07-01

Experiences in treatment of multiple sclerosis with natalizumab from a real-life cohort over 15 years

by Michael Auer, Anne Zinganell, Harald Hegen, Gabriel Bsteh, Franziska Di Pauli, Klaus Berek, Elena Fava, Sebastian Wurth, Thomas Berger, Florian Deisenhammer
Published 2021-12-01

Influence of physical activity on serum vitamin D levels in people with multiple sclerosis.

by Angelika Bauer, Ivan Lechner, Michael Auer, Thomas Berger, Gabriel Bsteh, Franziska Di Pauli, Harald Hegen, Sebastian Wurth, Anne Zinganell, Florian Deisenhammer
Published 2020-01-01